维普中文期刊产品整合服务
21篇 您的检索式:作者名="J Hasnan"
    题名 作者 年代 出处 被引量
1Expression of surviving and its elinicnpathological correlations in invasive ductal carcinoma of the breast 显示文摘AI-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
2Expression of surviving and its clinico - pathological correlations in invasive ductal careinomaof the breast显示文摘AI Joudi FS Iskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
3Expression of survivinand its clinicopathological correlations in invasive ductal carcino-ma of the breast显示文摘Al-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med J2007,48,7:1
4Expression of survivin and its clinicopatholngical correlations in invasive ductal carcinoma of the breast显示文摘AI-Joudi FS lskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
5Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus显示文摘Hasnan J Yusof MI Damitri TD 2010Singapore Med J2010,,:1
6Expression of Sur-vivin and its clinicopathological correlations in invasive ductalcarcinoma of breast 显示文摘Al-Joudi FS? Iskandar ZA Hasnan J 2007Singapore Med?2007,48,7:1
7牛骨异种移植物作为义眼座兔眼眶内植入术(英文)显示文摘目的:评价以牛骨作为义眼座在兔眼眶内植入的生物相容性。方法:在兔眼中用牛骨作为植入物,观察其生物相容性及其能否取代昂贵的人造植入物。把12只眼球内容摘除术后的新西兰白兔按眶内有没有植入牛骨分为两组:Y组(6只)为眼球摘除术后眶内没有植入牛骨,X组(6只)为眼球摘除术后植入牛骨。对12只新西兰白兔右眼行眼球内容物摘除,其中6例作为实验组行牛骨植入,6例作为对照组不植入。术后1,7,14,28,42d连续观察术眼的感染情况,植入物的移位情况,伤口愈合情况,眼球运动是否受限。术后42d,摘除实验组眼球,行组织病理检查,检测其炎性反应类型以及纤维血管增生情况。结果:连续临床观察显示:试验组和对照组在术后1d都有轻微的炎症反应,抗生素控制有效。试验组有1例在术后1d发生感染。但没有植入物的移位和脱出,没有伤口的裂开和眼球运动受限,也没有严重的感染和畸形出现。组织病理检查显示牛骨纤维生长良好,有轻微的排斥反应。结论:实验表明在兔眼中,牛骨作为义眼座植入有良好的生物相容性,而且其成本较低,易被接受。S Mohd Mansor H K Tan I Shatriah W H Wan Hazabbah J Hasnan 2007国际眼科杂志2007,7,6:1
8Expression of Survivin and its clinicopathological correlations in invasive ductal carcinoma of breast 显示文摘AI-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
9Coronary artery bypass grafting without cardiopulmonary bypas- an attractive alternative in high risk patients显示文摘BERGSLAND J HASNAN S LEWIN A N 1997Eur J Cardiothorac Surg1997,11,:1
10Expression of survivin and its clinieopathological correlations in invasive ductal carcinoma of the breast显示文摘Al-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med J2007,48,7:1
11Relationship between apoptotie markers ( Bax and BCL-2) and biochemical markers in type 2 diabetes mellitus 显示文摘Hasnan J Yusof MI Damitri TD 2010Singapore Med J2010,51,:1
12Coronary bypass artery grafting without cardiopulmonary bypass:an attractive alternative in high risk patients 显示文摘BERGSLAND J HASNAN S LEWIN A N 1997Eur J Cardiothorac Surg1997,11,:1
13Relationship between apoptotic markers ( bax and bcl-2 ) and biochemical markers in type 2 diabetes mellitus 显示文摘Hasnan J Yusof MI Damitri TD 2010Singapore Med J2010,51,1:1
14Expression of survivin and its clinical pathological correlations in invasive ductal carcinoma of the breast显示文摘A1-Joudi FS Iskandar ZA Hasnan J et a l 2007Singapore Med J2007,48,7:1
15Expression of surviving and its clinico-pathological correlations in invasive dustal carcinoma of the breast显示文摘 lskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
16Expression of SOX2and its clinicopathological correlations in invasive ductal carcinoma of the breast显示文摘AI-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
17Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus显示文摘Hasnan J Yusof M I Damitri T D Faridah A R Adenan A S Norbaini T H 2010Singapore Med J2010,51,:1
18Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast显示文摘Al-Joudi FS Iskandar ZA Hasnan J 0,,07:1
19Expression of survivin and its clinieopathologlcal correlations in invasive duetal eareino- ms of the breast显示文摘A1 - Joudi FS Iskandar ZA Hasnan J 2007Singapore Med2007,48,7:1
20Expression of survivin and its clinical pathological correlations in invasive ductal carcinoma of the breast显示文摘A1-Joudi FS Iskandar ZA Hasnan J 2007Singapore Med J2007,48,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费